AP 112 Pill - blue round, 8mm
Pill with imprint AP 112 is Blue, Round and has been identified as Hyoscyamine Sulfate 0.125 mg. It is supplied by Franklin Pharmaceutical LLC.
Hyoscyamine is used in the treatment of Diverticulitis; Irritable Bowel Syndrome; Anesthesia; Anticholinesterase Poisoning; Neurogenic Bladder and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine 0.125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AP 112




Hyoscyamine Sulfate
- Imprint
- AP 112
- Strength
- 0.125 mg
- Color
- Blue
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Anticholinergics/antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Franklin Pharmaceutical LLC
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
mannitol,
stearic acid,
FD&C Blue No. 1,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
50532-0112 | Franklin Pharmaceutical LLC |
68220-0112 | Alaven Pharmaceuticals |
51525-0112 | Wallace Pharmaceuticals Inc. |
Related images for "AP 112"
More about hyoscyamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (115)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: anticholinergics/antispasmodics
- En español
Patient resources
- Hyoscyamine drug information
- Hyoscyamine Extended-Release Tablets
- Hyoscyamine Orally Disintegrating Tablets
- Hyoscyamine Sublingual Tablets
- Hyoscyamine Tablets
Other brands
Levsin, Hyosyne, Levsin SL, Oscimin, ... +6 more
Professional resources
- Hyoscyamine monograph
- Hyoscyamine Sulfate Elixir (FDA)
- Hyoscyamine Sulfate Extended-Release Tablets (FDA)
- Hyoscyamine Sulfate Injection (FDA)
- Hyoscyamine Sulfate Oral Drops (FDA)
Other brands
Levsin, Hyosyne, Levbid, Levsin SL, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.